A phase II/III trial of Epidiolex in patients with infantile spasms

Trial Profile

A phase II/III trial of Epidiolex in patients with infantile spasms

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 04 Dec 2017

At a glance

  • Drugs Cannabidiol (Primary)
  • Indications Infantile spasms
  • Focus Registrational; Therapeutic Use
  • Sponsors GW Pharmaceuticals
  • Most Recent Events

    • 04 Dec 2017 According to a GW Pharmaceuticals media release, data from this study is expected in Q1 2018.
    • 05 Dec 2016 Status changed from planning to recruiting, according to a GW Pharmaceuticals media release.
    • 24 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top